www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 05 Apr 2026 22:40:35 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netTue, 03 Mar 2026 23:05:31 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-reports-2025-form-10-k-15532407

EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Reports 2025 Form 10-K 03.03.2026 / 23:05 CET/CEST The issuer is solely responsible ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-reports-2025-form-10-k-15532407Tue, 24 Feb 2026 14:34:11 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-provides-corporate-and-structural-update-15512428 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Provides Corporate and Structural Update 24.02.2026 / 14:34 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-provides-corporate-and-structural-update-15512428Tue, 02 Dec 2025 14:34:41 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-highlights-safety-profile-of-its-plant-based-adhd-candidate-amid-growing-concerns-about-psychiatric-polypharmacy-in-the-united-states-15328178 EQS-News: ABVC BioPharma, Inc. / Key word(s): Healthcare ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-highlights-safety-profile-of-its-plant-based-adhd-candidate-amid-growing-concerns-about-psychiatric-polypharmacy-in-the-united-states-15328178Fri, 21 Nov 2025 14:34:31 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-receives-us-250-000-from-forseecon-vitargus-r-total-licensing-fee-up-to-us-33-5-million-us-816-000-already-received-15304375 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-receives-us-250-000-from-forseecon-vitargus-r-total-licensing-fee-up-to-us-33-5-million-us-816-000-already-received-15304375Tue, 18 Nov 2025 14:35:01 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-receives-us-240-000-licensing-payment-from-oncox-biopharma-total-licensing-payments-reach-approximately-us-2-53-million-15287939 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-receives-us-240-000-licensing-payment-from-oncox-biopharma-total-licensing-payments-reach-approximately-us-2-53-million-15287939Mon, 03 Nov 2025 14:06:03 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-reports-230-yoy-licensing-revenue-growth-and-181-asset-expansion-in-q3-2025-15176174 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025 03.11.2025 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-reports-230-yoy-licensing-revenue-growth-and-181-asset-expansion-in-q3-2025-15176174Fri, 31 Oct 2025 12:05:11 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-receives-additional-us-100-000-licensing-payment-from-oncox-biopharma-bringing-total-payments-to-us-695-950-15155736 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-receives-additional-us-100-000-licensing-payment-from-oncox-biopharma-bringing-total-payments-to-us-695-950-15155736Fri, 17 Oct 2025 13:34:21 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-highlighted-by-u-s-financial-media-as-one-of-the-best-biotech-investments-q3-licensing-revenue-reaches-1-27-million-with-clear-clinical-progress-across-cns-and-oncology-15090314 EQS-News: ABVC BioPharma, Inc. / Key word(s): Manufacturing ABVC BioPharma Highlighted by U.S. Financial Media as One of the Best Biotech Investments; Q3 Licensing Revenue ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-highlighted-by-u-s-financial-media-as-one-of-the-best-biotech-investments-q3-licensing-revenue-reaches-1-27-million-with-clear-clinical-progress-across-cns-and-oncology-15090314Wed, 08 Oct 2025 13:33:11 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-has-received-a-cumulative-total-of-us-566-000-under-forseecon-licensing-agreement-supporting-gmp-facility-in-hsinchu-for-vitargus-r-production-14970955 EQS-News: ABVC BioPharma, Inc. / Key word(s): Financial ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abvc-biopharma-has-received-a-cumulative-total-of-us-566-000-under-forseecon-licensing-agreement-supporting-gmp-facility-in-hsinchu-for-vitargus-r-production-14970955